Office of Science and Technology Policy:

Violation of the Antideficiency Act

GAO-12-200T: Published: Nov 2, 2011. Publicly Released: Nov 2, 2011.

Additional Materials:


Thomas H. Armstrong
(202) 512-8257


Office of Public Affairs
(202) 512-4800

This testimony discusses our October 11 opinion concerning the Office of Science and Technology Policy's (OSTP) use of appropriations for bilateral activities with the government of the People's Republic of China.

In the opinion, we determined that OSTP violated a statutory provision prohibiting the agency from using its appropriations for bilateral engagements with China or any Chinese-owned company. Because no funds were available for such purpose, OSTP's actions also violated the Antideficiency Act, a fiscal statute central to Congress's constitutional power of the purse.

Oct 6, 2016

Aug 19, 2016

Aug 12, 2016

Jul 29, 2016

Jul 28, 2016

Jul 13, 2016

Jul 11, 2016

Jun 13, 2016

Jun 6, 2016

Looking for more? Browse all our products here